Identification of the receptor subtype involved in the analgesic effect of neurotensin

Journal of Neuroscience

Volumn 19, Issue 1, 1999, Pages 503-510

  Dubuc, Isabelle ^a   Sarret, Philippe ^a   Labbé Jullié, Catherine ^a   Botto, Jean Marie ^a   Honoré, Eric ^a   Bourdel, Elisabeth ^b   Martinez, Jean ^b   Costentin, Jean ^a   Vincent, Jean Pierre ^a   Kitabgi, Patrick ^a   Mazella, Jean ^a,c  

^a CNRS   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Analgesia; Antisense; Levocabastine sensitive; Neurotensin; Oligodeoxynucleotide; Receptor

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; LEVOCABASTINE; MESSENGER RNA; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR ANTAGONIST; RECEPTOR SUBTYPE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG POTENCY; HYPOTHERMIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0032930831     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-01-00503.1999     Document Type: Article

References (35)

1. Akhtar S, Agrawal S (1997) In vivo studies with antisense oligonucleotides. Trends Pharmacol Sci 18:12-18.
2. Al-Rhodan NRF, Richelson E, Gilbert JA, McCormick DJ, Kanba KS, Pfenning MA, Nelson A, Larson EW, Yaksh TL (1991) Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem. Brain Res 557:227-235.
3. Behbehani MM (1992) Physiological mechanisms of the analgesic effect of neurotensin. Ann NY Acad Sci 668:253-265.
4. Behbehani MM, Pert A (1984) A mechanism for the analgesic effect of neurotensin as revealed by behavioural and electrophysiological techniques. Brain Res 324:35-47.
5. Bissette G, Nemeroff CB, Loosen PT, Prange AJ, Lipton MA (1976) Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature 262:607-609.
6. Botto JM, Guillemare E, Vincent JP, Mazella J (1997a) Effects of SR48692 on neurotensin-induced calcium-activated chloride currents in the Xenopus oocyte expression system. Agonist-like activity on the levocabastine-sensitive neurotensin receptor and absence of antagonist effect on the levocabastine-insensitive neurotensin receptor. Neurosci Lett 223:193-196.
7. Botto JM, Sarret P, Vincent JP, Mazella J (1997b) Identification and expression of a variant isoform of the levocabastine-sensitive neurotensin receptor in the mouse central nervous system. FEBS Lett 400:211-214.
8. Chalon P, Vita N, Kaghad M, Guillemot M, Bonnin J, Delpech B, Lefur G, Ferrara P, Caput D (1996) Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett 386:91-94.
9. Clineschmidt BV, McGuffin JC, Bunting PB (1979) Neurotensin: antinocisponsive action in rodents. Eur J Pharmacol 54:129-139.
10. Coquerel A, Dubuc I, Kitabgi P, Costentin J (1988) Potentiation by thiorphan and bestatin of the naloxone-insensitive analgesic effects of neurotensin and neuromedin N. Neurochem Int 12:361-366.
11. Cullen BR (1987) Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 152:684-704.
12. Doulut S, Rodriguez M, Lugrin D, Vecchini F, Kitabgi P, Aumelas A, Martinez J (1992) Reduced peptide bond pseudopeptide analogues of neurotensin. Pept Res 5:30-38.
13. Dubuc I, Costentin J, Terranova JP, Barnouin MC, Soubrié P, Lefur G, Rostène W, Kitabgi P (1994) The nonpeptide neurotensin antagonist, SR48692, used as a tool to reveal putative neurotensin receptor subtypes. Br J Pharmacol 112:352-354.
14. Gully D, Canton M, Boigegrain R, Jeanjean F, Molimard JC, Poncelet M, Gueudet C, Heaulme M, Leyris R, Brouard A, Pélaprat D, Labbé-Jullié C, Mazella J, Soubrié P, Maffrand JP, Rostène W, Kitabgi P, Le Fur G (1993) Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of neurotensin receptor. Proc Natl Acad Sci USA 90:65-69.
15. Haley TJ, Mc Cormick WG (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol 12:12-15.
16. Kitabgi P, Rostène W, Dussaillant M, Schotte A, Laduron PM, Vincent JP (1987) Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution. Eur J Pharmacol 140:285-293.
17. Koster R, Anderson M, De Beer EJ (1959) Acetic acid for analgesic screening. Fed Proc 18:412-415.
18. Labbé-Jullié C, Dubuc I, Brouard A, Doulut S, Bourdel E, Pelaprat D, Mazella J, Martinez J, Rostène W, Costentin J, Kitabgi P (1994) In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes. J Pharmacol Exp Ther 268:328-336.
19. Martin GE, Naruse T (1982) Differences in the pharmacological actions of intrathecally administered neurotensin and morphine. Regul Pept 3:97-103.
20. Mazella J, Chabry J, Kitabgi P, Vincent JP (1988) Solubilization and characterization of active neurotensin receptors from mouse brain. J Biol Chem 263:144-149.
21. Mazella J, Botto JM, Guillemare E, Coppola T, Sarret P, Vincent, JP (1996) Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain. J Neurosci 16:5613-5620.
22. Mazella J, Zsürger N, Navarro V, Chabry J, Kaghad M, Caput D, Ferrara P, Vita P, Gully D, Maffrand JP, Vincent JP (1998) The 100 kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J Biol Chem 273:26273-26276.
23. Nemeroff CB, Osbahr III AJ, Manberg PJ, Erwin GN, Prange AMJ (1979) Alteration in nociception and body temperature after intracisternal administration of neurotensin, β-endorphine, other endogenous peptides and morphine. Proc Natl Acad Sci USA 76:5368-5371.
24. Nicot A, Rostène W, Bérod A (1994) Neurotensin receptor expression in the rat forebrain and midbrain: a combined analysis by in situ hybridization and receptor autoradiography. J Comp Neurol 341:407-419.
25. Phillips MI, Gyurko R (1995) In vivo applications of antisense oligonucleotides for peptide research. Regul Pept 59:131-141.
26. Sadoul JL, Mazella J, Kitabgi P, Vincent JP (1984) Preparation of neurotensin selectively iodinated on the tyrosine 3 residue: biological activity and binding properties on mammalian neurotensin receptors. Biochem Biophys Res Commun 120:812-819.
27. Sarret P, Beaudet A, Vincent JP, Mazella J (1998) Regional and cellular distribution of low affinity neurotensin receptor mRNA in adult and developing mouse brain. J Comp Neurol 394:344-356.
28. 3H-neurotensin binding sites in rat brain. Naunyn Schmiedebergs Arch Pharmacol 333:400-405.
29. Tanaka K, Masu M, Nakanishi S (1990) Structure and functional expression of the cloned rat neurotensin receptor. Neuron 4:847-854.
30. Tyler BM, Cusack B, Douglas CL, Souder T, Richelson E (1998a) Evidence for additional neurotensin receptor subtypes: neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociception. Brain Res 792:246-252.
31. Tyler BM, McCormick DJ, Hoshall CV, Douglas CL, Jansen K, Lacy BW, Cusack B, Richelson E (1998b) Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo. FEBS Lett 421:280-284.
32. Vincent JP (1995) Neurotensin receptors: binding properties, transduction pathways, and structure. Cell Mol Neurobiol 15:501-512.
33. Vita N, Laurent P, Lefort S, Chalon P, Dumont X, Kaghad M, Gully D, Le Fur G, Ferrara P, Caput D (1993) Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett 317:139-142.
34. Wahlestedt C, Golanov E, Yamamoto S, Yee F, Ericson H, Yoo H, Inturrisi CE, Reis DJ (1993a) Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 363:260-263.
35. Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M (1993b) Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259:528-531.